{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T21:25:27Z","timestamp":1785014727113,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hidaka Research Project","award":["4-D-1\u201313"],"award-info":[{"award-number":["4-D-1\u201313"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04197-z","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T12:52:54Z","timestamp":1755089574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of PINK1 protein expression as a predictive marker for the efficacy of adjuvant chemotherapy in colorectal cancer: a retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Takatsugu","family":"Fujii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Hirasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Kamakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikashi","family":"Hiranuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumitsu","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sakuramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"4197_CR1","doi-asserted-by":"publisher","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK et al. NCCN Guidelines Version 3.2021 Colon Cancer Continue NCCN Guidelines Panel Disclosures. 2021;19:329\u2013\u200959. https:\/\/doi.org\/10.6004\/jnccn.2021.0012","DOI":"10.6004\/jnccn.2021.0012"},{"key":"4197_CR2","doi-asserted-by":"publisher","unstructured":"Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22:3408\u201319. https:\/\/doi.org\/10.1200\/JCO.2004.05.063.","DOI":"10.1200\/JCO.2004.05.063"},{"key":"4197_CR3","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1200\/JCO.2007.15.8261","volume":"26","author":"MJ O\u2019Connell","year":"2008","unstructured":"O\u2019Connell MJ, Campbell ME, Goldberg RM, Grothey A, Seitz JF, Benedetti JK, et al. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set. J Clin Oncol. 2008;26:2336\u201341. https:\/\/doi.org\/10.1200\/JCO.2007.15.8261.","journal-title":"J Clin Oncol"},{"key":"4197_CR4","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJMOA010957","volume":"345","author":"DJ Sargent","year":"2001","unstructured":"Sargent DJ, Goldberg RM, Jacobson SD, Macdonald JS, Labianca R, Haller DG, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med. 2001;345:1091\u20137. https:\/\/doi.org\/10.1056\/NEJMOA010957.","journal-title":"N Engl J Med"},{"key":"4197_CR5","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","volume":"27","author":"T Andr\u00e9","year":"2009","unstructured":"Andr\u00e9 T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27:3109\u201316. https:\/\/doi.org\/10.1200\/JCO.2008.20.6771.","journal-title":"J Clin Oncol"},{"key":"4197_CR6","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer for the multicenter international study of Oxaliplatin\/5-Fluorouracil\/Leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. N Engl J Med. 2004;350:2343\u201351. https:\/\/doi.org\/10.1056\/NEJMoa032709.","journal-title":"N Engl J Med"},{"key":"4197_CR7","doi-asserted-by":"publisher","unstructured":"Hamacher-Brady A, Brady NR. Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy. 2016;73:775\u201395. https:\/\/doi.org\/10.1007\/s00018-015-2087-8","DOI":"10.1007\/s00018-015-2087-8"},{"key":"4197_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBAMCR.2024.119752","volume":"1871","author":"K Deepak","year":"2024","unstructured":"Deepak K, Roy PK, Das CK, Mukherjee B, Mandal M. Mitophagy at the crossroads of cancer development: exploring the role of mitophagy in tumor progression and therapy resistance. Biochimica et Biophysica Acta (BBA). 2024;1871: 119752. https:\/\/doi.org\/10.1016\/J.BBAMCR.2024.119752.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"4197_CR9","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.ebiom.2019.02.032","volume":"41","author":"L Wu","year":"2019","unstructured":"Wu L, Zhang D, Zhou L, Pei Y, Zhuang Y, Cui W, et al. FUN14 domain-containing 1 promotes breast cancer proliferation and migration by activating calcium-NFATC1-BMI1 axis. EBioMedicine. 2019;41:384\u201394. https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.032.","journal-title":"EBioMedicine"},{"key":"4197_CR10","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.3892\/OR.2017.5486\/HTML","volume":"37","author":"R Zhang","year":"2017","unstructured":"Zhang R, Gu J, Chen J, Ni J, Hung J, Wang Z, et al. High expression of PINK1 promotes proliferation and chemoresistance of NSCLC. Oncol Rep. 2017;37:2137\u201346. https:\/\/doi.org\/10.3892\/OR.2017.5486\/HTML.","journal-title":"Oncol Rep"},{"key":"4197_CR11","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1245\/S10434-017-6096-8","volume":"24","author":"K Yamashita","year":"2017","unstructured":"Yamashita K, Miyata H, Makino T, Masuike Y, Furukawa H, Tanaka K, et al. High expression of the mitophagy-related protein PINK1 is associated with a poor response to chemotherapy and a poor prognosis for patients treated with neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Ann Surg Oncol. 2017;24:4025\u201332. https:\/\/doi.org\/10.1245\/S10434-017-6096-8.","journal-title":"Ann Surg Oncol"},{"key":"4197_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12876-023-02975-1","volume":"24","author":"Y Mihara","year":"2024","unstructured":"Mihara Y, Hirasaki M, Horita Y, Fujino T, Fukushima H, Kamakura Y, et al. PTEN-induced kinase 1 gene single-nucleotide variants as biomarkers in adjuvant chemotherapy for colorectal cancer: a retrospective study. BMC Gastroenterol. 2024;24:67. https:\/\/doi.org\/10.1186\/s12876-023-02975-1.","journal-title":"BMC Gastroenterol"},{"key":"4197_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41419-022-04922-6","volume":"13","author":"S Wang","year":"2022","unstructured":"Wang S, Jiang X, Xie X, Yin J, Zhang J, Liu T, et al. PiR-823 inhibits cell apoptosis via modulating mitophagy by binding to PINK1 in colorectal cancer. Cell Death Dis. 2022;13:465. https:\/\/doi.org\/10.1038\/s41419-022-04922-6.","journal-title":"Cell Death Dis"},{"key":"4197_CR14","doi-asserted-by":"publisher","first-page":"6506","DOI":"10.3390\/ijms24076506","volume":"24","author":"J Carlos Celis-Pinto","year":"2023","unstructured":"Carlos Celis-Pinto J, Fern\u00e1ndez-Velasco AA, Corte-Torres MD, Santos-Juanes J, Blanco-Agud\u00edn N, Pi\u00f1a Batista KM, et al. PINK1 Immunoexpression predicts survival in patients undergoing hepatic resection for colorectal liver metastases. Int J Mol Sci. 2023;24:6506. https:\/\/doi.org\/10.3390\/ijms24076506.","journal-title":"Int J Mol Sci"},{"key":"4197_CR15","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.21037\/TCR-24-933","volume":"13","author":"H Liu","year":"2024","unstructured":"Liu H, Huang Y, Zhao C, Wang G, Wang X. ABALON regulates mitophagy and 5-FU sensitivity in colorectal cancer via PINK1-Parkin pathway. Transl Cancer Res. 2024;13:6201\u201318. https:\/\/doi.org\/10.21037\/TCR-24-933.","journal-title":"Transl Cancer Res"},{"key":"4197_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/pin.13350","volume":"73","author":"Y Ichinose","year":"2023","unstructured":"Ichinose Y, Hasebe T, Hirasaki M, Sakakibara A, Yokogawa H, Nukui A, et al. Vimentin-positive invasive breast carcinoma of no special type: a breast carcinoma with lethal biological characteristics. Pathol Int. 2023;73:413\u201333. https:\/\/doi.org\/10.1111\/pin.13350.","journal-title":"Pathol Int"},{"key":"4197_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/FJC.0000000000001552","volume":"83","author":"Y Takenaka","year":"2024","unstructured":"Takenaka Y, Hirasaki M, Bono H, Nakamura S, Kakinuma Y. Transcriptome analysis reveals enhancement of cardiogenesis-related signaling pathways by S-Nitroso- N -Pivaloyl- d -penicillamine: implications for improved diastolic function and cardiac performance. J Cardiovasc Pharmacol. 2024;83:433\u201345. https:\/\/doi.org\/10.1097\/FJC.0000000000001552.","journal-title":"J Cardiovasc Pharmacol"},{"key":"4197_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell AM, Youle RJ. The roles of PINK1, parkin and mitochondrial fidelity in parkinson\u2019s disease. Neuron. 2015;85:257\u201373. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.007.","journal-title":"Neuron"},{"key":"4197_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/S13046-023-02823-W\/FIGURES\/7","volume":"42","author":"F Zheng","year":"2023","unstructured":"Zheng F, Zhong J, Chen K, Shi Y, Wang F, Wang S, et al. PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway. J Exp Clin Cancer Res. 2023;42:295. https:\/\/doi.org\/10.1186\/S13046-023-02823-W\/FIGURES\/7.","journal-title":"J Exp Clin Cancer Res"},{"key":"4197_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10059-012-0100-8","volume":"34","author":"H Koh","year":"2012","unstructured":"Koh H, Chung J. PINK1 as a molecular checkpoint in the maintenance of mitochondrial function and integrity. Mol Cells. 2012;34:7\u201313. https:\/\/doi.org\/10.1007\/s10059-012-0100-8.","journal-title":"Mol Cells"},{"key":"4197_CR21","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1080\/1061186X.2020.1867992","volume":"29","author":"YH Qiu","year":"2021","unstructured":"Qiu YH, Zhang TS, Wang XW, Wang MY, Zhao WX, Zhou HM, et al. Mitochondria autophagy: a potential target for cancer therapy. J Drug Target. 2021;29:576\u201391. https:\/\/doi.org\/10.1080\/1061186X.2020.1867992.","journal-title":"J Drug Target"},{"key":"4197_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.4161\/AUTO.22968","volume":"9","author":"W Martinet","year":"2013","unstructured":"Martinet W, Schrijvers DM, Timmermans JP, Bult H, De Meyer GR. Immunohistochemical analysis of macroautophagy: recommendations and limitations. Autophagy. 2013;9:386\u2013402. https:\/\/doi.org\/10.4161\/AUTO.22968.","journal-title":"Autophagy"},{"key":"4197_CR23","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.4081\/EJH.2015.2481","volume":"59","author":"AM Schl\u00e4fli","year":"2015","unstructured":"Schl\u00e4fli AM, Berezowska S, Adams O, Langer R, Tschan MP. Reliable LC3 and p62 autophagy marker detection in formalin fixed paraffin embedded human tissue by immunohistochemistry. Eur J Histochem. 2015;59:2481. https:\/\/doi.org\/10.4081\/EJH.2015.2481.","journal-title":"Eur J Histochem"},{"key":"4197_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/S12957-016-0946-X\/TABLES\/4","volume":"14","author":"KJ Schmitz","year":"2016","unstructured":"Schmitz KJ, Ademi C, Bertram S, Schmid KW, Baba HA. Prognostic relevance of autophagy-related markers LC3, p62\/sequestosome 1, Beclin-1 and ULK1 in colorectal cancer patients with respect to KRAS mutational status. World J Surg Oncol. 2016;14:189. https:\/\/doi.org\/10.1186\/S12957-016-0946-X\/TABLES\/4.","journal-title":"World J Surg Oncol"},{"key":"4197_CR25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/embor.2012.14","volume":"13","author":"AW Greene","year":"2012","unstructured":"Greene AW, Grenier K, Aguileta MA, Muise S, Farazifard R, Haque ME, et al. Mitochondrial processing peptidase regulates PINK1 processing, import and parkin recruitment. EMBO Rep. 2012;13:378\u201385. https:\/\/doi.org\/10.1038\/embor.2012.14.","journal-title":"EMBO Rep"},{"issue":"3","key":"4197_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031099","volume":"21","author":"AL Scherr","year":"2020","unstructured":"Scherr AL, Jassowicz A, Pat\u00f3 A, Elssner C, Ismail L, Schmitt N, et al. Knockdown of Atg7 induces Nuclear-LC3 dependent apoptosis and augments chemotherapy in colorectal cancer cells. Int J Mol Sci. 2020; 21:1099. https:\/\/doi.org\/10.3390\/ijms21031099.","journal-title":"Int J Mol Sci"},{"key":"4197_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.canlet.2017.02.012","volume":"416","author":"Y Lei","year":"2018","unstructured":"Lei Y, Zhang D, Yu J, Dong H, Zhang J, Yang S. Mini-review targeting autophagy in cancer stem cells as an anticancer therapy. Cancer Lett. 2018;416:149. https:\/\/doi.org\/10.1016\/j.canlet.2017.02.012.","journal-title":"Cancer Lett"},{"key":"4197_CR28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/J.PHRS.2016.01.028","volume":"105","author":"C Wang","year":"2016","unstructured":"Wang C, Hu Q, Shen HM. Pharmacological inhibitors of autophagy as novel cancer therapeutic agents. Pharmacol Res. 2016;105:164\u201375. https:\/\/doi.org\/10.1016\/J.PHRS.2016.01.028.","journal-title":"Pharmacol Res"},{"key":"4197_CR29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/15548627.2015.1033601","volume":"11","author":"B Pasquier","year":"2015","unstructured":"Pasquier B. SAR405, a PIK3C3\/VPS34 inhibitor that prevents autophagy and synergizes with MTOR inhibition in tumor cells. Autophagy. 2015;11:725\u20136. https:\/\/doi.org\/10.1080\/15548627.2015.1033601.","journal-title":"Autophagy"},{"key":"4197_CR30","doi-asserted-by":"publisher","first-page":"14729","DOI":"10.1073\/pnas.1216844110","volume":"110","author":"A Berthier","year":"2013","unstructured":"Berthier A, Jim\u00e9nez-S\u00e1inz J, Pulido R. PINK1 regulates histone H3 trimethylation and gene expression by interaction with the polycomb protein EED\/WAIT1. Proc Natl Acad Sci U S A. 2013;110:14729\u201334. https:\/\/doi.org\/10.1073\/pnas.1216844110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4197_CR31","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3390\/CANCERS120615233","volume":"12","author":"Y Fu","year":"2020","unstructured":"Fu Y, Gu Q, Luo L, Xu J, Luo Y, Xia F, et al. New anti-cancer strategy to suppress colorectal cancer growth through Inhibition of ATG4B and lysosome function. Cancers. 2020;12:1523. https:\/\/doi.org\/10.3390\/CANCERS120615233.","journal-title":"Cancers"}],"updated-by":[{"DOI":"10.1186\/s12876-026-04657-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000}}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04197-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04197-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04197-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:18:55Z","timestamp":1770290335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04197-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4197"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04197-z","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12876-026-04657-0","URL":"https:\/\/doi.org\/10.1186\/s12876-026-04657-0","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the ethical standards of the Declaration of Helsinki and its subsequent amendments. This study was approved by the Institutional Review Board of the Saitama Medical University International Medical Center (2022-135). The requirement for informed consent was waived by the Institutional Review Board of Saitama Medical University International Medical Center (2022-135) in view of the retrospective nature of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"582"}}